Friday, May 1, 2026

How Upstage Studio’s AI Transforms Document Handling: A Comprehensive Guide

Upstage launched its AI document processing solution, Upstage Studio, enabling swift data extraction and user-friendly management.

Kim Jong Un’s Regime Uses Sports Diplomacy to Re-enter Global Stage Amid US Pressure

North Korea plans to send a delegation of 260-270 members to the 2026 Aichi-Nagoya Asian Games, including 150 athletes in 17 sports.

Bae’s Back: Pirates Prospect Powers Through After Injury!

Pittsburgh Pirates' Bae Ji Hwan has shaken...

Tag: R&D

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Cha Biotech Announces Support of K-Bio Startups at Bio Korea 2026

Cha Biotech aims to create a global innovation ecosystem for K-Bio startups through the K-Bio CIC Open Innovation Center.

How the 2026 Drug Price Reform Will Reshape the Pharmaceutical Industry

Experts discuss the impact of drug pricing reform on the pharmaceutical sector, urging innovation and strategic shifts in R&D investments.

Samjin Pharm Selected as Leading Biotech Firm in Government-Backed ‘World Class Plus’ Project

Samjin Pharm selected for the "World Class Plus Project" to enhance global competitiveness in biotech with innovative drug developments.

Inventage Lab Secures 985 Billion KRW: What This Means for Long-Lasting Injection Solutions

Inventage Lab secures 985 billion KRW to enhance its drug delivery platform, focusing on long-acting injectables for obesity and more.

SK Nexilis to Showcase 4-Micrometer Ultra-Wide Copper Foil at InterBattery 2026

SK Nexilis will showcase innovative copper foil technology at InterBattery 2026, enhancing productivity for battery manufacturers.

Future of EV Batteries—Dongwha Electrolyte’s R&D Roadmap Revealed

Dongwha Electrolyte will present its R&D roadmap and strategies for global battery regulations at InterBattery 2026 in Seoul.

Can Samjin Pharm Overcome Generic Drug Price Cuts With AI-Driven Drug Development?

Samjin Pharm shifts focus to R&D, moving away from generics to innovative drug development, amid government price cuts.

Samsung Biologics Joins CEPI: How This Partnership Will Revolutionize Vaccine Production in Asia

Samsung Biologics partners with CEPI to enhance vaccine manufacturing, aiming to strengthen global health security and support local biotech growth.

Chinese & Indian Medical Invasion: Pharmaceutic Dependency on Risk of Essential Medicine Supply

Concerns rise over South Korea's API industry reliance on China and India, with self-sufficiency at a record low of 25.6% in 2023.

South Korea’s Auto Industry Is Being Hollowed Out—And No One’s Sounding the Alarm

South Korea's auto industry faces challenges from global competition, requiring R&D enhancements and local production incentives for future mobility.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.